Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Neoadjuvant administration of gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in large or locally advanced operable breast cancer: A phase II study

Trial Profile

Neoadjuvant administration of gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in large or locally advanced operable breast cancer: A phase II study

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2010

At a glance

  • Drugs Cisplatin; Doxorubicin; Gemcitabine
  • Indications Breast cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 02 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top